• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国的益生菌。

Probiotics in the United States.

作者信息

Vanderhoof Jon A, Young Rosemary

机构信息

Harvard Medical School and Children's Hospital, Boston, Massachusetts, USA.

出版信息

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S67-72; discussion S144-51. doi: 10.1086/523339.

DOI:10.1086/523339
PMID:18181726
Abstract

Probiotics are live microbial products that have a defined health benefit. Scientific research has established that there are validated indications for the use of some probiotics available in the United States; however, in many cases, they are often used for conditions for which no benefit has been established. This article will review the uses of probiotics in the United States, as well as the current state of regulatory issues surrounding probiotics. Although the use and scientific understanding of probiotics are rapidly increasing, it is evident that there is a need to clarify the regulatory issues, which, at present, are unclear and subject to misinterpretation. In addition to efficacy, safety issues must be considered in determining when and how probiotics are to be used.

摘要

益生菌是具有明确健康益处的活微生物制品。科学研究已证实,美国市面上的某些益生菌有经过验证的适用症;然而,在许多情况下,它们常被用于尚未证实有益的病症。本文将综述美国益生菌的使用情况,以及围绕益生菌的监管问题现状。尽管对益生菌的使用和科学认识正在迅速增加,但显然有必要澄清目前尚不清楚且容易被误解的监管问题。除了疗效外,在确定何时以及如何使用益生菌时,还必须考虑安全性问题。

相似文献

1
Probiotics in the United States.美国的益生菌。
Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S67-72; discussion S144-51. doi: 10.1086/523339.
2
Clinical research on probiotics: the interface between science and regulation.益生菌的临床研究:科学与监管的交汇点
Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S101-3; discussion S144-51. doi: 10.1086/523332.
3
Regulation of probiotic substances as ingredients in foods: premarket approval or "generally recognized as safe" notification.作为食品成分的益生菌物质的监管:上市前批准或“一般认为安全”通知。
Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S115-8; discussion S144-51. doi: 10.1086/523329.
4
Safe and efficacious probiotics: what are they?安全有效的益生菌:它们是什么?
Trends Microbiol. 2006 Aug;14(8):348-52. doi: 10.1016/j.tim.2006.06.006. Epub 2006 Jun 30.
5
Probiotics: definition, sources, selection, and uses.益生菌:定义、来源、选择及用途。
Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S58-61; discussion S144-51. doi: 10.1086/523341.
6
Current marketplace for probiotics: a Japanese perspective.当前益生菌市场:日本视角
Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S73-5; discussion S144-51. doi: 10.1086/523338.
7
[Safety of probiotics--a review].[益生菌的安全性——综述]
Wei Sheng Wu Xue Bao. 2008 Feb;48(2):257-61.
8
Prophylactic and therapeutic uses of probiotics: a review.益生菌的预防和治疗用途:综述
J Am Diet Assoc. 2001 Feb;101(2):229-38; quiz 239-41. doi: 10.1016/S0002-8223(01)00060-8.
9
Health-benefit claims for probiotic products.益生菌产品的健康益处声明。
Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S122-4; discussion S144-51. doi: 10.1086/523327.
10
Probiotics: facts and myths.益生菌:事实与误解
Clin Microbiol Infect. 2005 Dec;11(12):958-66. doi: 10.1111/j.1469-0691.2005.01228.x.

引用本文的文献

1
Effect of hot-melt extruded leaves on intestinal microflora and epithelial cells.热熔挤压叶片对肠道微生物群和上皮细胞的影响。
Heliyon. 2023 Dec 19;10(1):e23954. doi: 10.1016/j.heliyon.2023.e23954. eCollection 2024 Jan 15.
2
Probiotics and Their Bioproducts: A Promising Approach for Targeting Methicillin-Resistant and Vancomycin-Resistant .益生菌及其生物制品:一种针对耐甲氧西林和耐万古霉素的有前景的方法
Microorganisms. 2023 Sep 25;11(10):2393. doi: 10.3390/microorganisms11102393.
3
Kombucha: Perceptions and Future Prospects.康普茶:认知与未来展望。
Foods. 2022 Jul 4;11(13):1977. doi: 10.3390/foods11131977.
4
Effect of Probiotics on Respiratory Tract Allergic Disease and Gut Microbiota.益生菌对呼吸道过敏性疾病和肠道微生物群的影响。
Front Nutr. 2022 Feb 22;9:821900. doi: 10.3389/fnut.2022.821900. eCollection 2022.
5
Utilizing Probiotics for the Prevention and Treatment of Gastrointestinal Diseases.利用益生菌预防和治疗胃肠道疾病。
Front Microbiol. 2021 Aug 9;12:689958. doi: 10.3389/fmicb.2021.689958. eCollection 2021.
6
Probiotic Supplementation and Food Intake and Knowledge Among Patients and Consumers.益生菌补充剂与患者和消费者的食物摄入及相关知识
Probiotics Antimicrob Proteins. 2020 Sep;12(3):824-833. doi: 10.1007/s12602-019-09602-0.
7
Probiotics Reduce Health Care Cost and Societal Impact of Flu-Like Respiratory Tract Infections in the USA: An Economic Modeling Study.益生菌降低美国类似流感的呼吸道感染的医疗保健成本和社会影响:一项经济建模研究。
Front Pharmacol. 2019 Aug 28;10:980. doi: 10.3389/fphar.2019.00980. eCollection 2019.
8
Gut Microbiota and Cancer: From Pathogenesis to Therapy.肠道微生物群与癌症:从发病机制到治疗
Cancers (Basel). 2019 Jan 3;11(1):38. doi: 10.3390/cancers11010038.
9
Probiotics for vulvovaginal candidiasis in non-pregnant women.非孕妇外阴阴道念珠菌病的益生菌治疗
Cochrane Database Syst Rev. 2017 Nov 23;11(11):CD010496. doi: 10.1002/14651858.CD010496.pub2.
10
Randomised controlled trial of (LGG) versus placebo in children presenting to the emergency department with acute gastroenteritis: the PECARN probiotic study protocol.急性胃肠炎患儿就诊于急诊科时,双歧杆菌(LGG)与安慰剂的随机对照试验:PECARN 益生菌研究方案。
BMJ Open. 2017 Sep 24;7(9):e018115. doi: 10.1136/bmjopen-2017-018115.